189 related articles for article (PubMed ID: 25774383)
1. Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors.
Cartier E; Hamilton PJ; Belovich AN; Shekar A; Campbell NG; Saunders C; Andreassen TF; Gether U; Veenstra-Vanderweele J; Sutcliffe JS; Ulery-Reynolds PG; Erreger K; Matthies HJ; Galli A
EBioMedicine; 2015 Feb; 2(2):135-146. PubMed ID: 25774383
[TBL] [Abstract][Full Text] [Related]
2. Syntaxin 1 Ser
Shekar A; Mabry SJ; Cheng MH; Aguilar JI; Patel S; Zanella D; Saleeby DP; Zhu Y; Romanazzi T; Ulery-Reynolds P; Bahar I; Carter AM; Matthies HJG; Galli A
Sci Adv; 2023 Jan; 9(2):eadd8417. PubMed ID: 36630507
[TBL] [Abstract][Full Text] [Related]
3. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder.
Hamilton PJ; Campbell NG; Sharma S; Erreger K; Herborg Hansen F; Saunders C; Belovich AN; ; Sahai MA; Cook EH; Gether U; McHaourab HS; Matthies HJ; Sutcliffe JS; Galli A
Mol Psychiatry; 2013 Dec; 18(12):1315-23. PubMed ID: 23979605
[TBL] [Abstract][Full Text] [Related]
4. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.
Bowton E; Saunders C; Reddy IA; Campbell NG; Hamilton PJ; Henry LK; Coon H; Sakrikar D; Veenstra-VanderWeele JM; Blakely RD; Sutcliffe J; Matthies HJ; Erreger K; Galli A
Transl Psychiatry; 2014 Oct; 4(10):e464. PubMed ID: 25313507
[TBL] [Abstract][Full Text] [Related]
5. Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors.
DiCarlo GE; Aguilar JI; Matthies HJ; Harrison FE; Bundschuh KE; West A; Hashemi P; Herborg F; Rickhag M; Chen H; Gether U; Wallace MT; Galli A
J Clin Invest; 2019 May; 129(8):3407-3419. PubMed ID: 31094705
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
Doolen S; Zahniser NR
J Pharmacol Exp Ther; 2001 Mar; 296(3):931-8. PubMed ID: 11181926
[TBL] [Abstract][Full Text] [Related]
8. Ack1 is a dopamine transporter endocytic brake that rescues a trafficking-dysregulated ADHD coding variant.
Wu S; Bellve KD; Fogarty KE; Melikian HE
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15480-5. PubMed ID: 26621748
[TBL] [Abstract][Full Text] [Related]
9. Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia.
Aguilar JI; Cheng MH; Font J; Schwartz AC; Ledwitch K; Duran A; Mabry SJ; Belovich AN; Zhu Y; Carter AM; Shi L; Kurian MA; Fenollar-Ferrer C; Meiler J; Ryan RM; Mchaourab HS; Bahar I; Matthies HJ; Galli A
Elife; 2021 May; 10():. PubMed ID: 34002696
[TBL] [Abstract][Full Text] [Related]
10. Palmitoylation mechanisms in dopamine transporter regulation.
Rastedt DE; Vaughan RA; Foster JD
J Chem Neuroanat; 2017 Oct; 83-84():3-9. PubMed ID: 28115272
[TBL] [Abstract][Full Text] [Related]
11. Mode-Selective Raman Imaging of Dopamine-Human Dopamine Transporter Interaction in Live Cells.
Silwal AP; Lu HP
ACS Chem Neurosci; 2018 Dec; 9(12):3117-3127. PubMed ID: 30024721
[TBL] [Abstract][Full Text] [Related]
12. Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in
Campbell NG; Shekar A; Aguilar JI; Peng D; Navratna V; Yang D; Morley AN; Duran AM; Galli G; O'Grady B; Ramachandran R; Sutcliffe JS; Sitte HH; Erreger K; Meiler J; Stockner T; Bellan LM; Matthies HJG; Gouaux E; Mchaourab HS; Galli A
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3853-3862. PubMed ID: 30755521
[TBL] [Abstract][Full Text] [Related]
13. Leaky lessons learned: Efflux prone dopamine transporter variant reveals sex and circuit specific contributions of D2 receptor signalling to neuropsychiatric disease.
Mayer FP; Stewart A; Blakely RD
Basic Clin Pharmacol Toxicol; 2024 Feb; 134(2):206-218. PubMed ID: 37987120
[TBL] [Abstract][Full Text] [Related]
14. The dopamine transporter proteome.
Torres GE
J Neurochem; 2006 Apr; 97 Suppl 1():3-10. PubMed ID: 16635244
[TBL] [Abstract][Full Text] [Related]
15. Silencing of
Lanzo A; Safratowich BD; Kudumala SR; Gallotta I; Zampi G; Di Schiavi E; Carvelli L
Front Physiol; 2018; 9():576. PubMed ID: 29872404
[TBL] [Abstract][Full Text] [Related]
16. [The dopamine transporter: characterization and physiopathologic implications].
Thibaut F; Vaugeois JM; Petit M
Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
[TBL] [Abstract][Full Text] [Related]
17. Autism-Associated Variant in the SLC6A3 Gene Alters the Oral Microbiome and Metabolism in a Murine Model.
DiCarlo GE; Mabry SJ; Cao X; McMillan C; Woynaroski TG; Harrison FE; Reddy IA; Matthies HJG; Flynn CR; Wallace MT; Wu H; Galli A
Front Psychiatry; 2021; 12():655451. PubMed ID: 33935841
[No Abstract] [Full Text] [Related]
18. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.
Bolan EA; Kivell B; Jaligam V; Oz M; Jayanthi LD; Han Y; Sen N; Urizar E; Gomes I; Devi LA; Ramamoorthy S; Javitch JA; Zapata A; Shippenberg TS
Mol Pharmacol; 2007 May; 71(5):1222-32. PubMed ID: 17267664
[TBL] [Abstract][Full Text] [Related]
19. Pharmacochaperoning in a
Asjad HMM; Kasture A; El-Kasaby A; Sackel M; Hummel T; Freissmuth M; Sucic S
J Biol Chem; 2017 Nov; 292(47):19250-19265. PubMed ID: 28972153
[TBL] [Abstract][Full Text] [Related]
20. Zn(2+) reverses functional deficits in a de novo dopamine transporter variant associated with autism spectrum disorder.
Hamilton PJ; Shekar A; Belovich AN; Christianson NB; Campbell NG; Sutcliffe JS; Galli A; Matthies HJ; Erreger K
Mol Autism; 2015; 6():8. PubMed ID: 25741436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
